Novel topical booster enhances follicular sulfotransferase activity in patients with androgenetic alopecia: a new strategy to improve minoxidil response
J Eur Acad Dermatol Venereol
.
2020 Dec;34(12):e799-e800.
doi: 10.1111/jdv.16645.
Epub 2020 Jun 10.
Authors
P M Ramos
1
,
J McCoy
2
,
C Wambier
3
,
J Shapiro
4
,
S Vañó-Galvan
5
,
R Sinclair
6
,
A Goren
2
Affiliations
1
Department of Dermatology and Radiotherapy, São Paulo State University (UNESP), Botucatu, SP, Brazil.
2
Applied Biology, Irvine, CA, USA.
3
Department of Dermatology, The Warren Alpert Medical School, Brown University, Providence, RI, USA.
4
The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, USA.
5
Servício de Dermatología, Hospital Universitario Ramón y Cajal, Madrid, Spain.
6
Sinclair Dermatology, Melbourne, VIC, Australia.
PMID:
32432358
DOI:
10.1111/jdv.16645
No abstract available
Publication types
Letter
MeSH terms
Administration, Topical
Alopecia* / drug therapy
Hair Follicle
Humans
Minoxidil* / therapeutic use
Sulfotransferases / therapeutic use
Substances
Minoxidil
Sulfotransferases